Novo Nordisk Market Cap

Novo Nordisk has a market cap or net worth of $214.27 billion as of December 5, 2025. Its market cap has decreased by -52.92% in one year.

Market Cap

214.27B

Enterprise Value

224.96B

Revenue

49.58B

Ranking

n/a

PE Ratio

13.14

Stock Price

$48.84

Market Cap Chart

Since February 18, 1997, Novo Nordisk's market cap has increased from 7.15B to 214.27B, an increase of 2,898.29%. That is a compound annual growth rate of 12.53%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	214.27B	-44.46%
Dec 30, 2024	385.82B	-16.41%
Dec 29, 2023	461.55B	51.61%
Dec 30, 2022	304.43B	19.34%
Dec 30, 2021	255.09B	56.58%
Dec 30, 2020	162.91B	19.30%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Veradigm	824.30M
Elite Pharmaceuticals	558.58M
Glass House Brands	531.36M
CytoDyn	403.93M
American Oncology Network	367.13M
Northwest Biotherapeutics	364.92M
Silence Therapeutics	336.78M
Nika Pharmaceuticals	259.91M

Market Cap Rankings